BioAtla Inc.

NASDAQ: BCAB · Real-Time Price · USD
0.48
-0.03 (-5.46%)
At close: Jun 10, 2025, 3:59 PM

BioAtla Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
49.05M 111.47M 215.51M 244.98M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a 154K 154K 154K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
447K 320K 539K 502K
Total Current Assets
51.23M 116.41M 220.43M 247.29M
Property-Plant & Equipment
1.19M 3.1M 5.15M 6.98M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.19M 3.25M 5.3M 7.13M
Total Assets
52.42M 119.66M 225.74M 254.42M
Account Payables
1.9M 3.82M 4.23M 1.18M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
836K n/a 1.52M 1.39M
Other Current Liabilities
11.8M 19.11M 12.41M 13.19M
Total Current Liabilities
14.54M 28.34M 23.13M 19.81M
Long-Term Debt
n/a n/a 2.46M 3.98M
Other Long-Term Liabilities
23.62M 19.81M 17.35M 15.82M
Total Long-Term Liabilities
23.62M 20.64M 22.27M 23.79M
Total Liabilities
38.16M 48.99M 45.4M 43.6M
Total Debt
836K 2.46M 3.98M 5.37M
Common Stock
6K 5K 5K 4K
Retained Earnings
-486.04M -416.26M -292.8M -186.32M
Comprehensive Income
n/a -0.00 n/a -0.00
Shareholders Equity
14.27M 70.67M 180.34M 210.82M
Total Investments
n/a n/a n/a n/a